{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T19:58:38Z","timestamp":1779047918460,"version":"3.51.4"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Swiss National Foundation","award":["PZ00P3_193206"],"award-info":[{"award-number":["PZ00P3_193206"]}]},{"DOI":"10.13039\/501100005688","name":"Gottfried Julia Bangerter-Rhyner Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016071","name":"Goldschmidt-Jacobson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016071","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hemmi Foundation"},{"name":"University and University Hospital of Basel"},{"DOI":"10.13039\/501100008485","name":"Swiss Academy of Medical Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Cigarette smoking cessation reduces cardiovascular risk via various mechanisms. Thereby, the role of blood pressure remains unclear, with studies reporting both decreased and increase blood pressure values after cessation, potentially influenced by weight change. We previously showed that the glucagon like peptide-1 analogue dulaglutide mitigates weight gain after smoking cessation. This secondary analysis investigates the effect of smoking cessation on blood pressure changes in dulaglutide- vs. placebo-treated individuals. We hypothesized a beneficial effect of smoking cessation on blood pressure, particularly in dulaglutide-treated participants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This is a predefined secondary analysis of a randomized, double-blind, placebo-controlled trial. Participants (n = 255) underwent a 12-week smoking cessation programme including standard of care (behavioural counselling and varenicline) with weekly injections of dulaglutide 1.5 mg or placebo, followed by a follow-up of 52 weeks. The primary outcome was change in systolic blood pressure after 52 weeks in abstinent vs. smoking individuals. Further outcomes included blood pressure and body weight changes at Week 12 and 52 according to smoking status and treatment arms. A path analysis was performed to estimate direct and indirect effect of different variables on systolic blood pressure changes. Two hundred and eighteen out of 255 participants with complete blood pressure readings were included in the analyses. Across the entire study population, systolic blood pressure was stable over the period of 52 weeks after smoking cessation despite a weight gain of +3 kg (0, 5.4) at Week 52. Blood pressure reductions were seen in the subgroups of participants with minimal weight gain \u22643 kg [\u22124.6 mmHg (\u22129, 3)] and in individuals with hypertensive blood pressure values at baseline [\u221216 mmHg (\u221222, 2)]. Dulaglutide treatment reduced body weight and blood pressure initially, followed by a weight rebound and a blood pressure increase of +7.5 mmHg (\u22121, 15) at Week 52. The path analysis identified weight as an important factor influencing blood pressure during smoking cessation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our analysis suggests that smoking cessation may have a beneficial effect on blood pressure- especially in hypertensive individuals-, counteracting the expected blood pressure increase caused by post-cessation weight gain. However, it also underlines the importance of weight control after smoking cessation as a crucial factor in smoking cessation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Registration<\/jats:title>\n                  <jats:p>ClinicalTrials.gov: NCT 03204396.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf055","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T18:07:26Z","timestamp":1741111646000},"page":"1394-1402","source":"Crossref","is-referenced-by-count":5,"title":["Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatment"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8556-1075","authenticated-orcid":false,"given":"Julia","family":"Beck","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Hasenb\u00f6hler","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Werlen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Lengsfeld","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Meienberg","sequence":"additional","affiliation":[{"name":"Medical Outpatient Department and Hypertension Clinic, ESH Hypertension Centre of Excellence, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cemile","family":"Bathelt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Vogt","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-0965","authenticated-orcid":false,"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6373-9820","authenticated-orcid":false,"given":"Thilo","family":"Burkard","sequence":"additional","affiliation":[{"name":"Medical Outpatient Department and Hypertension Clinic, ESH Hypertension Centre of Excellence, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Cardiology, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8305-2700","authenticated-orcid":false,"given":"Bettina","family":"Winzeler","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel , Petersgraben 4, 4031 Basel ,","place":["Switzerland"]},{"name":"Department of Clinical Research, University of Basel , Petersplatz 1, 4001 Basel ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"2025100919515049900_zwaf055-B1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4178\/epih.e2017026","article-title":"The association between smoking or passive smoking and cardiovascular diseases using a Bayesian hierarchical model: based on the 2008\u20132013 Korea Community Health Survey","volume":"39","author":"Lee","year":"2017","journal-title":"Epidemiol Health"},{"key":"2025100919515049900_zwaf055-B2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(12)61720-6","article-title":"The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK","volume":"381","author":"Pirie","year":"2013","journal-title":"Lancet (London, England)"},{"key":"2025100919515049900_zwaf055-B3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/eurjpc\/zwad285","article-title":"Association of tobacco smoke exposure with metabolic profile from childhood to early adulthood: the Special Turku Coronary Risk Factor Intervention Project","volume":"31","author":"Lehtovirta","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2025100919515049900_zwaf055-B4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MBP.0b013e32833e439f","article-title":"Acute effects of passive smoking on blood pressure and heart rate in healthy females","volume":"15","author":"Yarlioglues","year":"2010","journal-title":"Blood Press Monit"},{"key":"2025100919515049900_zwaf055-B5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tcm.2016.03.001","article-title":"Cardiovascular toxicity of nicotine: implications for electronic cigarette use","volume":"26","author":"Benowitz","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"2025100919515049900_zwaf055-B6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0895-7061(96)00487-6","article-title":"Smoking related to 24-h ambulatory blood pressure and heart rate: a study in 352 normotensive Danish subjects","volume":"10","author":"Mikkelsen","year":"1997","journal-title":"Am J Hypertens"},{"key":"2025100919515049900_zwaf055-B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/01.HYP.37.2.187","article-title":"Association between smoking and blood pressure","volume":"37","author":"Primatesta","year":"2001","journal-title":"Hypertension"},{"key":"2025100919515049900_zwaf055-B8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0002-8703(86)90645-9","article-title":"Blood pressure in smokers and nonsmokers: epidemiologic findings","volume":"111","author":"Green","year":"1986","journal-title":"Am Heart J"},{"key":"2025100919515049900_zwaf055-B9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1161\/01.HYP.37.2.194","article-title":"Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study","volume":"37","author":"Lee","year":"2001","journal-title":"Hypertension"},{"key":"2025100919515049900_zwaf055-B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jhh.1001303","article-title":"An association between smoking habits and blood pressure in normotensive Japanese men","volume":"16","author":"Okubo","year":"2002","journal-title":"J Hum Hypertens"},{"key":"2025100919515049900_zwaf055-B11","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0002-8703(74)90492-X","article-title":"Effect of smoking on blood pressure","volume":"87","author":"Seltzer","year":"1974","journal-title":"Am Heart J"},{"key":"2025100919515049900_zwaf055-B12","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1365-2796.2003.01293.x","article-title":"Changes in blood pressure and body weight following smoking cessation in women","volume":"255","author":"Janzon","year":"2004","journal-title":"J Intern Med"},{"key":"2025100919515049900_zwaf055-B13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08037059609062111","article-title":"How smoking affects blood pressure","volume":"5","author":"Omvik","year":"1996","journal-title":"Blood Press"},{"key":"2025100919515049900_zwaf055-B14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/0002-8703(75)90320-8","article-title":"Changes associated with quitting cigarette smoking: the Framingham study","volume":"90","author":"Gordon","year":"1975","journal-title":"Am Heart J"},{"key":"2025100919515049900_zwaf055-B15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.18332\/tid\/186853","article-title":"Smoking cessation decreases arterial blood pressure in hypertensive smokers: a subgroup analysis of the randomized controlled trial GENTSMOKING","volume":"22","author":"Gaya","year":"2024","journal-title":"Tob Induc Dis"},{"key":"2025100919515049900_zwaf055-B16","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/bmjnph-2023-000781","article-title":"Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trial","volume":"6","author":"Baur","year":"2023","journal-title":"BMJ Nutr Prev Health"},{"key":"2025100919515049900_zwaf055-B17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13063-023-07164-9","article-title":"Glucagon-like peptide-1 analogues: a new way to quit smoking? (SKIP)\u2014a structured summary of a study protocol for a randomized controlled study","volume":"24","author":"Lengsfeld","year":"2023","journal-title":"Trials"},{"key":"2025100919515049900_zwaf055-B18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"2025100919515049900_zwaf055-B19","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"2025100919515049900_zwaf055-B20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"2025100919515049900_zwaf055-B21","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met + SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"key":"2025100919515049900_zwaf055-B22","doi-asserted-by":"crossref","first-page":"101865","DOI":"10.1016\/j.eclinm.2023.101865","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial","volume":"57","author":"Lengsfeld","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2025100919515049900_zwaf055-B23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eclinm.2024.102429","article-title":"Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial","volume":"68","author":"L\u00fcthi","year":"2024","journal-title":"EClinicalMedicine"},{"key":"2025100919515049900_zwaf055-B24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00846549","article-title":"Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire","volume":"12","author":"Fagerstrom","year":"1989","journal-title":"J Behav Med"},{"key":"2025100919515049900_zwaf055-B25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jamainternmed.2018.6551","article-title":"Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: a systematic review and meta-analysis","volume":"179","author":"Roerecke","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2025100919515049900_zwaf055-B26"},{"key":"2025100919515049900_zwaf055-B27"},{"key":"2025100919515049900_zwaf055-B28","author":"R Core Team"},{"key":"2025100919515049900_zwaf055-B29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: an R package for structural equation modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J Stat Softw"},{"key":"2025100919515049900_zwaf055-B30","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.2174\/138161210792062920","article-title":"Cigarette smoking and hypertension","volume":"16","author":"Virdis","year":"2010","journal-title":"Curr Pharm Des"},{"key":"2025100919515049900_zwaf055-B31","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300272","article-title":"Smoking cessation and short- and longer-term mortality","volume":"3","author":"Cho","year":"2024","journal-title":"NEJM Evid"},{"key":"2025100919515049900_zwaf055-B32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/eurjpc\/zwae040","article-title":"Global burden of cardiovascular disease attributable to smoking, 1990\u20132019: an analysis of the 2019 Global Burden of Disease Study","volume":"31","author":"Minhas","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"2025100919515049900_zwaf055-B33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41440-023-01549-8","article-title":"Association between weight gain following smoking cessation and development of hypertension in the future","volume":"47","author":"Ninomiya","year":"2024","journal-title":"Hypertens Res"},{"key":"2025100919515049900_zwaf055-B34","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1002\/jcsm.13639","article-title":"Lean mass longitudinally confounds sedentary time and physical activity with blood pressure progression in 2513 children","volume":"15","author":"Agbaje","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2025100919515049900_zwaf055-B35","doi-asserted-by":"crossref","first-page":"979042","DOI":"10.3389\/fnut.2022.979042","article-title":"The impact of body composition and fat distribution on blood pressure in young and middle-aged adults","volume":"9","author":"Zhao","year":"2022","journal-title":"Front Nutr"},{"key":"2025100919515049900_zwaf055-B36","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2025100919515049900_zwaf055-B37","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"2025100919515049900_zwaf055-B38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCULATIONAHA.124.069820","article-title":"Device-measured 24-hour movement behaviors and blood pressure: a 6-part compositional individual participant data analysis in the ProPASS consortium","volume":"151","author":"Blodgett","year":"2024","journal-title":"Circulation"},{"key":"2025100919515049900_zwaf055-B39","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O\u2019Neil","year":"2018","journal-title":"Lancet"},{"key":"2025100919515049900_zwaf055-B40","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf055\/62211852\/zwaf055.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/32\/14\/1394\/62211852\/zwaf055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/32\/14\/1394\/62211852\/zwaf055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T23:52:13Z","timestamp":1760053933000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/32\/14\/1394\/8046875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":40,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,3,3]]},"published-print":{"date-parts":[[2025,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf055","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,3,3]]}}}